(Q41077495)

26 September 2017

1 reference

title

Restenosis: pathophysiology and preventive strategies (English)

1 reference

26 September 2017

Phillips-Hughes J

1

1 reference

26 September 2017

Kandarpa K

series ordinal

2

1 reference

26 September 2017

publication date

1 May 1996

1 reference

Journal of Vascular and Interventional Radiology

26 September 2017

published in

1 reference

26 September 2017

volume

7

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

321-333

1 reference

26 September 2017

cites work

Noncoronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after successful coronary angioplasty in patients with single-vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Long-term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after successful coronary angioplasty. Pathophysiology and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Multilesion coronary angioplasty: clinical and angiographic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The basis of molecular strategies for treating coronary restenosis after angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Impact of different patency criteria on long-term results of femoropopliteal angioplasty: analysis of 106 consecutive patients with claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Recanalization of femoropopliteal occlusive lesions: a comparison of long-term clinical, color duplex US, and arteriographic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Defining coronary restenosis. Newer clinical and angiographic paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Mechanism of angioplasty and its relation to restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Experimental models of coronary artery restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

"Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters"--the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Laser balloon angioplasty: clinical, angiographic and histologic results

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after excimer laser angioplasty of coronary stenoses and chronic total occlusions

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Pathophysiology of the atherogenic process

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Endothelial dysfunction and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Analysis of the fluid dynamic effects on atherogenesis at branching sites

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Flow patterns and spatial distribution of atherosclerotic lesions in human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Antioxidants and atherosclerosis. A current assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Medical approaches to prevention of restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

In vivo technetium-99m S12 antibody imaging of platelet alpha-granules in rabbit endothelial neointimal proliferation after angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Deep arterial injury during experimental angioplasty: Relation to a positive indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after arterial angioplasty: A hemorrheologic response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Clinical applications of heparin-binding growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood Platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Monocyte chemotaxis: stimulation by specific exosite region in thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Signal transduction by the platelet-derived growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Oncogenes and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Role of phosphatidylinositol kinase in PDGF receptor signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The rat angiotensin II AT1A receptor couples with three different signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Multiple Signaling Pathways of V1-Vascular Vasopressin Receptors of A75rCells*

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The biology of platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

A role for oxygen radicals as second messengers

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Angiographic patterns of balloon inflation during percutaneous transluminal coronary angioplasty: role of pressure-diameter curves in studying distensibility and elasticity of the stenotic lesion and the mechanism of dilation

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Why restenosis after angioplasty appears and why it has been so difficult to prevent

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. A study in the atherosclerotic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Coronary angioplasty with gradual versus rapid balloon inflation: initial results and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Coronary angioplasty performed with gradual and prolonged inflation using a perfusion balloon catheter: procedural success and restenosis rate

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Progressive coronary dilation: an angioplasty technique that creates controlled arterial injury and reduces complications

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Does the speed of balloon deflation affect the complication rate of coronary angioplasty?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Hemodynamic evaluation of arterial stenoses by computer simulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Novel approach to the analysis of restenosis after the use of three new coronary devices

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Directional coronary atherectomy: how much lumen enlargement is optimal?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Clinical trials of restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Effects of low-dose aspirin on restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial. Study group on pharmacological treatment after PTA

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Dipyridamole directly inhibits vascular smooth muscle cell proliferation in vitro and in vivo: implications in the treatment of restenosis after angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

A new approach for local intravascular drug delivery. Iontophoretic balloon

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Gene transfer into vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

The emerging concept of vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi C

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2896%2972862-2

7 January 2021

10.1016/S1051-0443(96)72862-2

Identifiers

DOI

1 reference

26 September 2017

1 reference